Nuray Erin

8PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 10, 2021
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.

Christiana M Neophytou, Ioannis P Trougakos, Nuray Erin

|Apr 24, 2020
NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.

Esra Nizam, Sadi Köksoy, Nuray Erin

|Jan 09, 2020
Role of sensory neurons, neuroimmune pathways, and transient receptor potential vanilloid 1 (TRPV1) channels in a murine model of breast cancer metastasis.

Nuray Erin

|Dec 08, 2019
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.

Nuray Erin, Sayra Dilmaç, Anna Curry

|Sep 16, 2019
HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.

Şule Kale, Aylin F Korcum, Ertuğrul Dündar

|May 03, 2018
Correction to: Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer.

Nuray Erin, Nur Ogan, Azmi Yerlikaya

Pageof 2

Frequent Collaborators

1 joint publications

Ioannis P Trougakos

1 joint publications

Panagiotis Papageorgis